allogeneic


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to allogeneic: zooplastic

al·lo·ge·ne·ic

 (ăl′ə-jə-nē′ĭk) also al·lo·gen·ic (-jĕn′ĭk)
adj.
Being genetically different although belonging to or obtained from the same species: allogeneic tissue grafts.
[allo- + Greek geneā, race; see genə- in Indo-European roots + -ic.]
al′lo·ge·ne′i·cal·ly adv.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

allogeneic

(ˈælədʒəˌneɪɪk) or

allogenic

adj
being genetically different, while belonging to the same species
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

al•lo•ge•ne•ic

(ˌæl oʊ dʒəˈni ɪk)

also al•lo•gen•ic

(-əˈdʒɛn ɪk)

adj.
(of cells, tissues, etc.) related but sufficiently dissimilar in genotype to interact antigenically: an allogeneic graft.
[1885–90]
al`lo•ge•ne′i•cal•ly, adv.
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.allogeneic - denoting or relating to cells or tissues from individuals belonging to the same species but genetically dissimilar (and hence immunologically incompatible)
xenogeneic - denoting or relating to cells or tissues from individuals belonging to different species
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Mentioned in ?
References in periodicals archive ?
"The second quarter was an important one on many fronts, from advancing our pipeline with the clearance of our second investigational new drug application, to designing our state-of-the-art manufacturing facility and the continued onboarding of highly-skilled employees who are passionate about bringing allogeneic cell therapy to patients," said David Chang, M.D., Ph.D., President, Chief Executive Officer and Co-Founder of Allogene.
Allogene Therapeutics reports Q2 EPS (41c), consensus (46c)
M2 PHARMA-June 13, 2019-Viralym-M Granted Regenerative Medicine Advanced Therapy Designation for the Treatment of Hemorrhagic Cystitis Caused by BK Virus in Adults and Children Following Allogeneic HSCT
Viralym-M Granted Regenerative Medicine Advanced Therapy Designation for the Treatment of Hemorrhagic Cystitis Caused by BK Virus in Adults and Children Following Allogeneic HSCT
WARREN, N.J., March 29, 2019 -- Celgene spinout company Celularity, Inc., announced results from two Phase 1 studies of PNK-007, an investigational allogeneic off-the-shelf natural killer (NK) cell therapy, in patients with acute myeloid leukemia (AML) and in patients with multiple myeloma (MM).
Results Of Phase 1 Studies Of Allogeneic Placental-Derived Cell Therapy: Cell Therapy Evaluated In Acute Myeloid Leukemia, Multiple Myeloma Patients
Cryoport, a temperature-controlled logistics company, has been selected by allogeneic cell therapy company, Celularity, to utilize its complete range of temperature-controlled solutions.
Cryoport, Celularity Enter Supply Chain Partnership
The FDA approved a Phase 2 clinical trial using an allogeneic mesenchymal stem cell-based drug, the first in Taiwan and in Asia to obtain the second Phase of U.S.
FDA Approves Zhong Ensheng's Clinical Phase 2 Trial Of Allogeneic Stem Cells In U.S
FDA approved the company's second -Phase clinical implementation of a new drag using allogeneic mesenchymal stem cells.
FDA Approves Zhong Ensheng's Clinical Phase 2 Trial Of Alloqeneic Stem Cells In U.S
SR-aGvHD is a leading cause of death following an allogeneic stem cell transplant the product is claimed to be differentiated by its high microbial diversity and richness that can restore the patient's functional microbiome with the aim of re-establishing homeostasis.
MaaT Pharma doses first patient in phase two clinical trial of MaaT013
New Jersey, US-based allogeneic immune-oncology company Celularity has agreed to acquire Colorado, US-based family cord blood bank CariCord, established by the University of Colorado and ClinImmune Labs, the company said.
Deal snapshot: CELULARITY ACQUIRES CARICORD TO ADVANCE STEM CELL TRANSPLANTATION
8, 2018 (HealthDay News) -- Individuals who underwent allogeneic blood or marrow transplantation (BMT) in childhood have elevated risk of late mortality 25 years or more after transplantation, according to a study published online July 26 in JAMA Oncology.
Elevated Late Mortality Persists After Blood or Marrow Transplant; But in past 3 decades, decrease in late mortality seen among those who underwent BMT in childhood
Allogene is advancing its allogeneic CAR T portfolio acquired from Pfizer which included the rights to 16 preclinical CAR T assets licensed from Cellectis and Servier and U.S.
Allogene Therapeutics, Inc. appoints Eric Schmidt, Ph.D. as Chief Financial Officer
(NYSE: PFE) and Allogene for Pfizer's portfolio of assets related to allogeneic chimeric antigen receptor T cell (CAR T) therapy, an investigational immune cell therapy approach to treating cancer.
Allogene Therapeutics Completes Agreement for Pfizer's Allogeneic CAR T Immuno-­oncology Portfolio

Dictionary browser ?
Full browser ?